ImpediMed Limited

ASX (AUD): ImpediMed Limited (IPD)

Last Price

0.029

Today's Change

-0.001 (3.44%)

Day's Change

0.028 - 0.029

Trading Volume

3,800,039

Profile
IPD

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Parmjot Bains M.D. Dr. Parmjot Bains M.D.

Full Time Employees:  83 83

IPO Date:  2007-10-24 2007-10-24

CIK: 

ISIN:  AU000000IPD8 AU000000IPD8

CUSIP:  Q48619102 Q48619102

Beta:  2.34 2.34

Last Dividend:  0.00 0.00

Dcf Diff:  0.03 0.03

Dcf:  -0.00 -0.00

Description

ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.

Address

50 Parker Court,
Pinkenba, QLD 4008, AU

61 7 3860 3700

http://www.impedimed.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment